retatrutide phase 3 trial dosing schedule Eli Lilly's clinical studies investigating retatrutide, the "triple-G" agonist, have found that long-term use can achieve substantial weight loss. Read about the work via the link in the comments Retatrutide dose schedule: complete week-by-week

Millions of people have used it since FDA approval, and the side effect profile is well-characterized

Patients can choose a convenient time for the injection, but it should be administered at the same time each day

Remove any air bubbles before injecting

Diabetes, insurance covers: $25-$100/mo copay for Ozempic, Mounjaro, Trulicity, Rybelsus, Victoza

Ozempic is approved to treat type 2 diabetes Wegovy is specifically approved for chronic weight management In some cases, providers may prescribe Ozempic off-label for weight management when appropriate, but Wegovy is the formulation designed and approved for weight loss